Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.

Ahmad I, Iyer A, Marginean CE, Yeh MM, Ferrell L, Qin L, Bifulco CB, Jain D.

Hum Pathol. 2009 May;40(5):726-34. doi: 10.1016/j.humpath.2008.10.018. Epub 2009 Jan 20.

PMID:
19157505
[PubMed - indexed for MEDLINE]
2.

Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.

Iyer A, Robert ME, Bifulco CB, Salem RR, Jain D.

Hum Pathol. 2008 Sep;39(9):1370-7. doi: 10.1016/j.humpath.2008.01.015. Epub 2008 Jul 7.

PMID:
18602664
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.

Joseph NM, Ferrell LD, Jain D, Torbenson MS, Wu TT, Yeh MM, Kakar S.

Mod Pathol. 2014 Jan;27(1):62-72. doi: 10.1038/modpathol.2013.114. Epub 2013 Jun 28.

PMID:
23807780
[PubMed - indexed for MEDLINE]
Free Article
4.

Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.

Kong CS, Appenzeller M, Ferrell LD.

Acta Cytol. 2000 Mar-Apr;44(2):218-22.

PMID:
10740609
[PubMed - indexed for MEDLINE]
5.

Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection.

Mounajjed T, Wu TT.

Am J Surg Pathol. 2011 Sep;35(9):1356-63. doi: 10.1097/PAS.0b013e31822280f3.

PMID:
21836491
[PubMed - indexed for MEDLINE]
6.

Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.

Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, Yen Y, Weiss LM, Chu PG.

Am J Surg Pathol. 2008 Mar;32(3):433-44. doi: 10.1097/PAS.0b013e318158142f.

PMID:
18300806
[PubMed - indexed for MEDLINE]
7.

Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.

Bioulac-Sage P, Cubel G, Taouji S, Scoazec JY, Leteurtre E, Paradis V, Sturm N, Nhieu JT, Wendum D, Bancel B, Ramos J, Paraf F, Saint Paul MC, Michalak S, Fabre M, Guettier C, Le Bail B, Zucman-Rossi J, Balabaud C.

Am J Surg Pathol. 2012 Nov;36(11):1691-9. doi: 10.1097/PAS.0b013e3182653ece.

PMID:
23060349
[PubMed - indexed for MEDLINE]
8.

Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.

Heukamp LC, Fischer HP, Schirmacher P, Chen X, Breuhahn K, Nicolay C, Büttner R, Gütgemann I.

Histopathology. 2006 Sep;49(3):242-7.

PMID:
16918970
[PubMed - indexed for MEDLINE]
9.

Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?

de Boer WB, Segal A, Frost FA, Sterrett GF.

Cancer. 2000 Oct 25;90(5):273-8.

PMID:
11038423
[PubMed - indexed for MEDLINE]
10.

Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy.

Tsai JH, Jeng YM, Pan CC, Lu SW, Kuo YJ.

Pathology. 2012 Dec;44(7):605-10. doi: 10.1097/PAT.0b013e32835817c6.

PMID:
22990279
[PubMed - indexed for MEDLINE]
11.

Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.

Lai JP, Chen ZM, Lok T, Chan OT, Himmelfarb E, Zhai Q, Lin F, Wang HL.

J Clin Pathol. 2014 Jun;67(6):464-9. doi: 10.1136/jclinpath-2013-201907. Epub 2014 Jan 9.

PMID:
24407433
[PubMed - indexed for MEDLINE]
12.

Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.

Paradis V, Benzekri A, Dargère D, Bièche I, Laurendeau I, Vilgrain V, Belghiti J, Vidaud M, Degott C, Bedossa P.

Gastroenterology. 2004 May;126(5):1323-9.

PMID:
15131793
[PubMed - indexed for MEDLINE]
13.
14.

Hepatic adenoma and focal nodular hyperplasia.

Shortell CK, Schwartz SI.

Surg Gynecol Obstet. 1991 Nov;173(5):426-31. Review.

PMID:
1658955
[PubMed - indexed for MEDLINE]
15.

[A clinicopathological study of hepatic focal nodular hyperplasia].

Ji Y, Zhu X, Tan Y, Zeng H, Ye Q, Tang Z.

Zhonghua Bing Li Xue Za Zhi. 2000 Oct;29(5):334-8. Chinese.

PMID:
11866930
[PubMed - indexed for MEDLINE]
16.

Diagnostic implications of albumin messenger RNA detection and cytokeratin pattern in benign hepatic lesions and biliary cystadenocarcinoma.

D'Errico A, Deleonardi G, Fiorentino M, Scoazec JY, Grigioni WF.

Diagn Mol Pathol. 1998 Dec;7(6):289-94.

PMID:
10207666
[PubMed - indexed for MEDLINE]
17.

Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.

Gouysse G, Frachon S, Hervieu V, Fiorentino M, d'Errico A, Dumortier J, Boillot O, Partensky C, Grigioni WF, Scoazec JY.

J Hepatol. 2004 Aug;41(2):259-66.

PMID:
15288475
[PubMed - indexed for MEDLINE]
18.

Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.

Wachter DL, Kristiansen G, Soll C, Hellerbrand C, Breuhahn K, Fritzsche F, Agaimy A, Hartmann A, Riener MO.

Histopathology. 2012 Jan;60(2):278-86. doi: 10.1111/j.1365-2559.2011.04091.x.

PMID:
22211286
[PubMed - indexed for MEDLINE]
19.

Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.

Koelma IA, Nap M, Huitema S, Krom RA, Houthoff HJ.

Arch Pathol Lab Med. 1986 Nov;110(11):1035-40.

PMID:
2430547
[PubMed - indexed for MEDLINE]
20.

Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study.

Washington K, Telen MJ, Gottfried MR.

Liver. 1997 Feb;17(1):17-23.

PMID:
9062875
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk